Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.
Quote | Abattis Bioceuticals Corp (OTCMKTS:ATTBF)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 25,300 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Abattis Bioceuticals Corp (OTCMKTS:ATTBF)
After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (“ Abattis ” or the “ Company ”) (OTC: AT...
Cannabis sales are determined by number of dispensaries and the availability to them by proximity. California has no restrictions regarding the number of dispensaries such as Washington State. Growth in cannabis in California will eclipse the entire cannabis industry's current ret...
Message Board Posts | Abattis Bioceuticals Corp (OTCMKTS:ATTBF)
Subject | By | Source | When |
---|---|---|---|
Up 9900% today - yaaay its a winner. | blueyedguy | investorshub | 11/15/2021 3:00:46 PM |
Did abattis go bankrupt? Or is all these | cj 13 | investorshub | 10/26/2021 3:10:50 PM |
re: post 32845. Not likely, all of | Mr Hand | investorshub | 09/27/2021 7:57:18 PM |
After 6 Years?....not a good idea Hen!... | Pennyes | investorshub | 08/09/2021 8:07:13 PM |
I'm not sure about that, I kicked it | Etailer | investorshub | 07/01/2021 1:55:16 AM |
News, Short Squeeze, Breakout and More Instantly...
Abattis Bioceuticals Corp Company Name:
ATTBF Stock Symbol:
OTCMKTS Market:
After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (“ Abattis ” or the “ Company ”) (OTC: AT...
VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis “) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company ...
VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) announces the filing of its annual financial statements for the year ended September 30, 2018 and is pleased to provide...